Explain this page
Arphra AIPlain-English read on Marvell Technology, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Quality composite
ATop tier
A snapshot of the latest fiscal year’s margins, returns on capital, balance-sheet strength and efficiency, computed from the income statement, balance sheet and cash-flow rows. Source income / balance / cash_flow.
Profitability
Gross margin51.0%
Operating margin16.3%
Net margin32.6%
ROE18.7%
ROA12.0%
ROIC7.1%
Liquidity & leverage
Current ratio2.01×
Quick ratio1.58×
Debt / equity0.33×
Net debt / EBITDA0.47×
Interest coverage7×
Efficiency & per-share
Asset turnover0.37×
Inventory days126
Days sales out.97
FCF / share$1.61
Book value / share$16.45
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Headline | |||||
| Market cap | $67.95B | — | — | — | — |
| Enterprise value | $70.1B | — | — | — | — |
| Multiples | |||||
| P / E | — | — | — | — | — |
| P / B | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / Sales | 8.55 | — | — | — | — |
| EV / FCF | 50.20 | — | — | — | — |
| Yields | |||||
| Earnings yield | +3.93% | — | — | — | — |
| Free cash flow yield | +2.06% | — | — | — | — |
| Dividend yield | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Margins | |||||
| Gross margin | +51.02% | +51.34% | +52.17% | +50.88% | +51.50% |
| Operating margin | +16.33% | +16.37% | +16.49% | +16.11% | +16.23% |
| EBITDA margin | +55.40% | +55.22% | +55.39% | +54.34% | +56.10% |
| EBIT margin | +39.65% | +39.81% | +39.95% | +38.75% | +38.77% |
| Pre-tax margin | +37.18% | +36.40% | +36.72% | +36.27% | +38.22% |
| Net margin | +32.58% | +16.46% | +16.68% | +15.85% | +16.39% |
| Cost structure | |||||
| Cost of revenue / sales | +48.98% | +48.80% | +49.40% | +47.77% | +48.20% |
| R&D intensity | +25.32% | +24.79% | +25.65% | +25.33% | +25.04% |
| SG&A intensity | +9.36% | +9.58% | +9.42% | +9.47% | +9.13% |
| Effective tax rate | +12.36% | +12.37% | +12.85% | +12.41% | +11.76% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity (ROE) | +18.66% | +9.48% | +9.53% | +8.91% | +9.42% |
| Return on assets (ROA) | +11.98% | +6.12% | +6.23% | +5.88% | +5.93% |
| Return on capital (ROC) | +7.01% | +7.03% | +7.02% | +6.85% | +6.95% |
| Return on invested capital (ROIC) | +13.98% | +7.07% | +7.10% | +6.74% | +7.02% |
| Asset turnover | +36.77% | +37.19% | +37.37% | +37.09% | +36.16% |
| DuPont · ROE decomposition | |||||
| Net margin | +32.58% | +16.46% | +16.68% | +15.85% | +16.39% |
| Asset turnover (× revenue / assets) | +36.77% | +37.19% | +37.37% | +37.09% | +36.16% |
| Equity multiplier (× assets / equity) | +155.75% | +154.97% | +152.83% | +151.58% | +158.91% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Turnover | |||||
| Asset turnover | 0.37 | 0.37 | 0.37 | 0.37 | 0.36 |
| Fixed-asset turnover | 6.72 | — | — | — | — |
| Inventory turnover | 2.89 | — | — | — | — |
| Receivables turnover | 3.75 | — | — | — | — |
| Payables turnover | — | — | — | — | — |
| Days outstanding | |||||
| Days sales outstanding (DSO) | 97.39 | — | — | — | — |
| Days inventory outstanding (DIO) | 126.22 | — | — | — | — |
| Days payables outstanding (DPO) | — | — | — | — | — |
| Cash conversion cycle | 223.61 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Operating CF / Net income | 0.66 | 1.30 | 1.25 | 1.37 | 1.33 |
| FCF / Net income | 0.52 | 1.03 | 1.00 | 1.05 | 1.02 |
| FCF margin | +17.04% | +16.87% | +16.70% | +16.66% | +16.65% |
| OCF margin | +21.36% | +21.45% | +20.89% | +21.79% | +21.83% |
| CapEx / Revenue | +4.32% | +4.29% | +4.30% | +4.42% | +4.26% |
| CapEx / D&A | 0.27 | — | — | — | — |
| Stock-based comp / Revenue | +7.21% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| EPS · diluted | 3.07 | 4.05 | 6.16 | 8.95 | 11.12 |
| EPS · basic | 3.10 | 4.02 | 6.18 | 8.95 | 11.08 |
| Book value / share | 16.45 | 23.09 | 33.43 | 46.27 | 53.83 |
| Tangible BV / share | 1.37 | 23.09 | 33.43 | 46.27 | 53.83 |
| Sales / share | 9.42 | 13.30 | 19.09 | 26.01 | 30.93 |
| Operating CF / share | 2.01 | 2.85 | 3.99 | 5.67 | 6.75 |
| Free cash flow / share | 1.61 | 2.24 | 3.19 | 4.33 | 5.15 |
| Dividends / share | 0.24 | 0.32 | 0.48 | 0.67 | 0.76 |
| Payout ratio | +7.68% | +14.78% | +14.98% | +16.21% | +15.04% |
| Retention ratio | +92.32% | +85.22% | +85.02% | +83.79% | +84.96% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E | 4y CAGR |
|---|---|---|---|---|---|---|
| Top-line | ||||||
| Revenue · YoY | — | +40.26% | +44.06% | +37.80% | +16.78% | +34.28% |
| Gross profit · YoY | — | +41.13% | +46.42% | +34.39% | +18.20% | +34.60% |
| Profit | ||||||
| Operating income · YoY | — | +40.62% | +45.06% | +34.63% | +17.63% | +34.06% |
| EBITDA · YoY | — | +39.80% | +44.51% | +35.18% | +20.57% | +34.71% |
| Net income · YoY | — | -29.16% | +46.02% | +30.91% | +20.82% | +13.10% |
| Operating | ||||||
| EBIT · YoY | — | +40.81% | +44.58% | +33.66% | +16.85% | +33.54% |
| R&D · YoY | — | +37.32% | +49.03% | +36.09% | +15.43% | +33.90% |
| Per-share | ||||||
| EPS · diluted · YoY | — | +31.76% | +52.23% | +45.31% | +24.31% | +37.97% |
| EPS · basic · YoY | — | +29.81% | +53.68% | +44.70% | +23.81% | +37.49% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2026 | 2027E | 2028E | 2029E | 2030E |
|---|---|---|---|---|---|
| Leverage | |||||
| Total debt | $4.79B | $6.81B | $9.9B | $13.08B | $15.83B |
| Net debt | $2.15B | $3.13B | $4.57B | $5.65B | $7.17B |
| Net debt / EBITDA | 0.47 | 0.49 | 0.50 | 0.46 | 0.48 |
| Debt / equity | 0.33 | 0.34 | 0.34 | 0.32 | 0.34 |
| Debt / assets | +21.50% | +22.04% | +22.35% | +21.26% | +21.48% |
| Equity / assets | +64.21% | +64.53% | +65.43% | +65.97% | +62.93% |
| Coverage | |||||
| EBITDA / interest expense | 22.41 | 22.75 | 23.05 | 22.10 | 22.72 |
| Operating income / interest | 6.61 | 6.75 | 6.86 | 6.55 | 6.57 |
| Interest expense | $202.6M | $279M | $397.98M | $561.06M | $657.91M |
| Liquidity | |||||
| Current ratio | 2.01 | — | — | — | — |
| Quick ratio | 1.50 | — | — | — | — |
| Cash ratio | 0.82 | — | — | — | — |
| Working capital | $3.24B | — | — | — | — |
| Working capital / revenue | +39.54% | — | — | — | — |
Historical multiples · μ ± σ bands
3 fiscal-year-end observations from key_metrics. Mean is dashed; light-green band is ±1σ, light-red band ±2σ. The dot marks the most recent value; the cheap / fair / rich verdict uses z-score against the issuer's own history (yields inverted — a high yield is cheap).
EV / Salescheap · z -1.03
μ 12.4 · σ 3.8 · current 8.6
EV / FCFcheap · z -1.19
μ 61.2 · σ 9.2 · current 50.2
Earnings yieldcheap · z 1.40
μ 0.5% · σ 2.5% · current 3.9%
FCF yieldcheap · z 1.21
μ 1.7% · σ 0.3% · current 2.1%
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
Valuation
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| P / E | — | — | — |
| P / B | — | — | — |
| EV / EBITDA | — | — | — |
| EV / Sales | 8.55x | 17.53x | 11.21x |
| Earnings yield | 3.9% | -0.9% | -1.6% |
| FCF yield | 2.1% | 1.4% | 1.7% |
Returns
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
| ROE | 18.7% | -6.6% | -6.3% |
| ROA | 12.0% | -4.4% | -4.4% |
| ROIC | 6.0% | -3.9% | -2.9% |
Leverage & liquidity
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Debt / equity | — | — | — |
| Net debt / EBITDA | 0.47 | 5.21 | 4.06 |
| Interest coverage | — | — | — |
| Current ratio | 2.01x | 1.54x | 1.69x |
| Quick ratio | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).